Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

LGBTQ+

- PMLiVE

Lilly thrown a lifeline on US Alimta patent

Court backs protection from generics until 2022

- PMLiVE

MannKind’s inhaled insulin backed for US approval

Afrezza finally on course for FDA approval in diabetes after two rejections

- PMLiVE

MHRA chairman steps down

Sir Gordon Duff leaves to join Oxford University

Pharma social media

Pharma must step up monitoring of social media

New service intends to help keep track of online patient communications

- PMLiVE

Developing your patient-centric strategy

How to succeed when your vehicle of engagement is not a disease

- PMLiVE

Doctors criticise FDA over Lemtrada rejection

Say Sanofi/Genzyme’s MS drug should have been approved

- PMLiVE

EU approval for Takeda’s schizophrenia drug

Latuda said to have improved side effect profile compared to other treatments

- PMLiVE

Astellas sets up regenerative medicine unit

Will spearhead company's efforts in cell-based therapies

- PMLiVE

GSK halts bid for Votrient maintenance use

Pulls European application for indication in advanced ovarian cancer

- PMLiVE

Sanofi appoints ‘chief patient officer’

Dr Anne Beal will lead pharma company’s efforts to improve its focus on patients

- PMLiVE

Portland Health appoints new associate director Matt Worrall

He joins as the London health comms agency celebrates its first anniversary

- PMLiVE

Print health ad spend in US remains buoyant

Companies paid $45m on advertising in professional print journals in January 2014, a 7 per cent rise year-on-year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links